This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: The Innovations of Stefan Schmitt
Introduction
Stefan Schmitt is a notable inventor based in Badenheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for manufacturing important compounds. With a total of 2 patents to his name, Schmitt's work has had a meaningful impact on medical advancements.
Latest Patents
Stefan Schmitt's latest patents include a process for the manufacture of dabigatran etexilate. This improved process focuses on preparing dabigatran etexilate, as well as analogous compounds of formula 7. His innovative approach enhances the efficiency and effectiveness of producing this crucial medication.
Career Highlights
Schmitt is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other talented professionals in the industry, furthering the development of groundbreaking medical solutions.
Collaborations
Some of his notable coworkers include Helmut Heitger and Rolf Dach. Their combined expertise contributes to the innovative environment at Boehringer Ingelheim, fostering advancements in pharmaceutical research and development.
Conclusion
Stefan Schmitt's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to innovation. His work continues to influence the industry and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile